No trial has tested weekly doses below 0.25 mg for weight loss, so any efficacy claims about true microdoses are extrapolations, not evidence
Patients who have other health conditions, such as diabetes, may already be at higher risk for muscle issues, which can make the problem worse over time
The overall survival was also affected with HR for premature death of 1.06 (1-1.12) for all-cause mortality and HR 1.21 (CI 1.05-1.38) for CVD
We used the force field parameters for single-protonated phosphorylated Ser (S1P) and Thr (T1P) residues developed by Sticht and co-workers 59
BMP4 was up-regulated in reactive astrocytes of SOD1 ALS rat model spinal ventral horns, and BMP4 knockdown through ASO suppressed glial activation and ameliorated the motor dysfunction (Shijo et al., 2018)
I generally enjoyed all of these, but links are not endorsements of every single detail in the piece or everything the writer ever wrote